|
Rare bone sarcoma: A retrospective analysis of 149 adult patients from the French Sarcoma Group. |
|
Pascaline Boudou-Rouquette |
Consulting or Advisory Role - Novartis; Roche |
Travel, Accommodations, Expenses - Amgen; Novartis; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Bayer (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bayer; GlaxoSmithKline; Lilly; Novartis; Pharmamar; Roche |
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Merck; Novartis; PharmaMar; Roche |
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst) |
Other Relationship - Innate Pharma |
|
|
No Relationships to Disclose |